Restricted accessCase reportFirst published online 2013-2
Immune reconstitution inflammatory syndrome Kaposi sarcoma in the liver manifesting as acute obstructive hepatitis: another potential role for montelukast?
Immune reconstitution inflammatory syndrome has been described in Kaposi sarcoma, but does not usually manifest as acute hepatitis. We describe a case of rapid obstructive jaundice after initiation of antiretroviral therapy, in which the liver biopsy confirmed hepatic Kaposi sarcoma, and the clinical course was altered by the addition of montelukast.
ScheidermanD, ArensonD, CelloJW. Hepatic disease in patients with the acquired immunodeficiency syndrome (AIDS).Hepatology1987; 7: 925-930
3.
LipmanMC, CardingSK. Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?AIDS2007; 21: 383-4
4.
LeidnerRS, AboulafiaDM. Recrudescent Kaposi's Sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.AIDS Patient Care and STDs2005; 19: 635-44
MartinJN, LakerM, KambuguA. Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation.Infect Agents Cancer2009; 4 (Supp. 2): O17
7.
VolkowPF, CornejoP, ZinserJW. Life threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome.AIDS2008; 22: 663-5
8.
GlasgowBJ, AndersK, LayfieldLJ, SteinsapirKD, GitnickGL, LewinKJ. Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS).Am J Clin Pathol1985; 83: 582-8
9.
SayerR, PaulJ, TukePW. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi Sarcoma?Int J STD AIDS2011; 22: 585-9
10.
LokeWC, SpittleMF, MitchellS, KulasegaramR. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.Int J STD AIDS2006; 17: 565-6
